Studies have indicated that there is a positive correlation between RECK expression in tumors and the survival outcome of patients with other types of tumors, including hepatocellular carcinoma (15), pancreatic cancer (14), breast cancer (16) and non-small cell lung cancer (17). This evidence concerns the gene RECK and hepatocellular carcinoma.